Fig. 1

Oncologic outcome of early and late recurrence group. A Overall survival in pTis/pTa/pT1 group. B Overall survival in pT2/pT3 group. C Cancer-specific survival in pTis/pTa/pT1 group. D Cancer-specific survival in pT2/pT3 group